Drug and target discovery
We deliver innovative drug and target discovery science to address to priority health and medical problems.
Department of Pharmacy & Pharmacology research
Our research spans fundamental drug discovery science, target identification through to health care delivery and lifelong health.
Research themes
We have a long-standing and internationally recognised reputation for high-quality, translational research with an overall aim of improved health outcomes.
Medicines design
Our aim is to understand and apply underlying scientific principles in the rational design of medicines.
Health and clinical research
This theme comprises two groups: Health services research and Musculoskeletal medicine.
Impact from our Research Excellence
91% of our research was rated world-leading or internationally excellent in the most recent Research Excellence Framework (REF2014). Learn more about how our research helps to shape a better future.
Treatment for drug addiction: how do patients cope in lockdown?
Despite big changes to their medication regimens, people being treated for drug addiction appear to be coping well in the pandemic.
New tool identifies which cancer patients are most likely to benefit from immunotherapy
A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalised medicine for cancer patients.
Easy to overdose on paracetamol if you’re selenium deficient, says research
People low on selenium are at risk of paracetamol overdose, even when they follow dosage recommendations, according to research involving Bath.
New drug discoveries are closely linked to the quality of lab procedures
High-quality lab procedures are even more crucial to identifying effective drugs than previously thought, new research from the University of Bath reveals.
Injections are two-and-a-half times safer when nurses use revamped guidelines
The NHS is changing the way it writes its guidelines for giving injections in hospitals, following groundbreaking research from the University of Bath.
Scientists behind needle-free diabetes monitor are finalists in a prestigious competition
A Bath team has been shortlisted for this year’s Emerging Technologies Competition run by the Royal Society of Chemistry.
Companies founded by our academics
Find out more about the companies which where founded by our academics. Some of them have now been acquired by major pharmaceutical companies.
Iksuda Therapeutics
Iksuda Therapeutics creates next-generation ADCs targeting difficult-to-treat cancers, including those that are resistant or refractory to current therapies.
Nanopharm Ltd.
The world’s leading provider of orally inhaled and nasal drug product design and development services - now acquired by Aptar Group.
Applied Molecular Transport
We are focused on developing novel oral medicines to treat autoimmune/inflammatory, gastrointestinal (GI) and metabolic diseases.
Vectura - Helping you bring inhaled medicines to market
Inhalation is our focus. With more than 20 years’ experience, we can help you succeed in bringing inhaled medicines to market.
Bath ASU - a pharmaceutical specials manufacturer based in Corsham, Wiltshire
Bath ASU produces thousands of life-changing medicines for patients in hospitals across the country.
Sterix Ltd.
The Bath-Imperial spin-out Sterix specialised in new-generation steroid-based therapeutics and was acquired by the French pharmaceutical company Ipsen.
Our Research Centres
Our research centres build a lively research community across intra- and interdisciplinary fields.
Centre for Therapeutic Innovation
We transform innovation, arisen from basic research, to diagnostics and prognostics, medicines design and delivery, leading to personalised medicine.
Cancer Research at Bath
Our mission is to improve cancer patient outcomes by fostering links between Bath’s scientists and clinicians.
Neuroscience network
An interdisciplinary group from psychology, biology and biochemistry, pharmacy and pharmacology, physics and computer science and local hospital research teams.
Our Contribution to Other Research Centres
We also support research in faculty- and university-wide interdisciplinary research centres.
Centre for Biosensors, Bioelectronics and Biodevices
We develop technologies to improve biomedical diagnosis, environmental monitoring, industrial bio-processes and our understanding of biological functions.
Centre for Mathematical Biology
We translate living systems into mathematical models in order to make quantitative predictions and inform biological experiments.
Centre for Nanoscience and Nanotechnology
We are an interdisciplinary research centre bridging science and engineering.
Centre for Sustainable & Circular Technologies
A multidisciplinary centre that brings together researchers with a strong interest in sustainability.
Institute for Mathematical Innovation
The Institute for Mathematical Innovation delivers multi-disciplinary and mathematically grounded research for real-world, societal and industrial challenges.
Centre for Pain Research (CPR)
Exploring pain. Finding new ways forward.
Our Facilities
Explore our state-of-the-art facilities available for teaching, research and industry with expert support from University staff.
Material and Chemical Characterisation Facility (MC²)
We combine cutting-edge analytical equipment with extensive in-house expertise to provide a comprehensive material and chemical characterisation service.
Doctoral Training
We offer projects over a broad spectrum of subject areas. Projects are available as part of Doctoral Training Partnerships as well as on an individual basis.
EPSRC Centre for Doctoral Training in Sustainable & Circular Technologies
Bath hosted multidisciplinary CDT, exploring the boundaries between chemical sciences and engineering.
EPSRC Centre for Doctoral Training in Statistical Applied Mathematics (SAMBa)
We train the future generation of interdisciplinary mathematicians, working at the interface of statistics with applied and computational mathematics.
MRC GW4 BioMed Doctoral Training Partnership
The GW4 BioMed MRC Doctoral Training Partnership aims to develop both medical and non-medical students into the next generation of medical researchers.
Doctoral College
We support and enrich the experience of our doctoral researchers and play a key role in developing policy and strategy relevant to doctoral study.
Postgraduate degrees in pharmacy and pharmacology
Find out about our PhD degrees, funding opportunities and how to apply.
UKRI CDT in ART-AI students
Meet the ART-AI students and read about their research interests and backgrounds.
Join us
Apply now for one of our academic positions.
Research Consortium
Find out more about research consortia in which we participate.
Major Grants
Find out more about some of our major research grants.
INFORM 2020
Molecules to Manufacture: Processing and Formulation Engineering of Inhalable Nanoaggregates and Microparticles
Early detection to improve outcome in patients with undiagnosed psoriatic arthritis
Psoriatic arthritis (PsA), an inflammatory arthritis, affects approximately 1 in 3 people with pre-existing psoriasis and up to 400,000 people in England.
Personalised hypobaric onychomycosis therapy
Engineering Personalised Cutaneous Hypobaric Microchambers that Deliver Antifungal Gas into the Human Nail to Treat Onychomycosis
New tools for acute spatiotemporal control of GPCR signalling in vivo
The G protein coupled receptor (GPCR) family are proteins that play important roles in virtually every body process, targeted in about a third of all medicines.
Assessing the skin pharmacokinetics of topical drugs
Assessing the skin pharmacokinetics of topical drugs, and the bio(in)equivalence of topical drug products, using non-invasive techniques
University of Bath and Qualasept Limited
To develop, validate and implement novel methods for the characterisation of drugs. New products will be produced that have extended shelf lives.